From the "Acquisition completed" update in November:
* At a 3% zinc cut-off, the higher grade Mineral Resource mainly associated with the Cathedral Vein is 1.8Mt at
5.6% zinc, 2.0% lead, 125 g/t silver and 0.2 g/t gold or 1.8Mt at 9.8% ZnEq*
* Majority of the Mineral Resource contained in the Measured and Indicated categories
* All veins remain open at depth and along strike & there is significant scope to increase the resource
* ~30% of the mineralised intercepts were not assayed for gold
The company also ran a Magneto-Telluric finding:
* Strong MT resistivity anomaly associated with zinc-silver-lead mineralisation
* MT anomaly extends for at least 1km along strike (ESE) beyond the existing Mineral
Resource and >1km at depth
The update also noted that there is copper potential at the site as well:
>5% copper at surface at Doris Loreto
* Large unexplored alteration anomaly at Loreto (porphyry-Cu potential)
* Loreto over-pegged by Codelco & BHP
* Loreto is 35km from BHP’s Cerro Colorado Mine (Mineral Resource of 400Mt at 0.62% copper)
The expected timeline going forward is (updated from the update to reflect current status):
* Finalisation of Permitting for Drilling [completed]
* Commencement of Drilling to Test Extensions to High-Grade Mineralisation [commenced]
* Drilling Results [between now and May 2017]
* Further Metallurgical Test Work to Optimise Recoveries [Expected May 2017]
* Upgrade Resource to JORC 2012 [Expected July 2017]
* Re-commencement of Feasibility Study [Expected 2nd Half 2017]
- Forums
- Commodities
- ZINC
- Zinc inventories break down through the 400K mark
ZINC
zinc futures
Add to My Watchlist
0.08%
!
$2,575.9

Zinc inventories break down through the 400K mark, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2,575.9 |
Change
0.000(0.08%) |
Mkt cap ! n/a |
Open | High | Low |
$2,575.9 | $0.00 | $0.00 |
Featured News
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online